The COVID-19 pandemic has forced many all over the world to stay indoors, including athletes. With many sporting events getting cancelled this year, a new report claims that the lack of an audience present at the stadiums may actually get athletes to perform better.
Express reports a study has found that athletes have somehow improved their performance when playing without an audience, especially as COVID-19 has gotten sports teams to adapt to what may seem to be the “new normal.” Unexpectedly, the report revealed that athletes, like those in Premier League football, were able to kick dead balls with more precision now than before. Their shooting has now improved without getting distracted by the cheers from the fans.
The NBA has also somehow found the same thing. NBA players in practice were able to make more free-throws and score more corner three-pointers than ever. These unexpected effects came as a result of having to stay home and make the most of their “time off” from playing by practicing their skills at home, in their backyards or driveways.
According to Arsenal manager Mikael Arteta, “When they play in front of 80,000 people it is much more difficult” compared to when they are playing in an empty stadium.
Meanwhile, there has yet to be a cure developed for COVID-19, but scientists are already on their way in developing a proper vaccine for the disease. ABC News reports that the Texas Medical Board in charge of licensing doctors and physicians in the state has issued a warning that they may take action if they are found to be falsely advertising a so-called cure for COVID-19.
The board issued the warning following the comments made by Houston-based pastor and doctor Dr. Stella Immanuel, touted hydroxychloroquine as a cure for COVID-19. However, many studies have already shown that the drug has no effect on curing the disease despite it being constantly touted by Donald Trump. The Food and Drug Administration has also warned consumers against using it as a treatment or as a preventative measure.
Unfortunately, several doctors have already prescribed the drug to dozens of Americans who tested positive for COVID-19. The medical board has since clarified that there is no definitive cure as of now for the disease, and that scientists are still in the midst of developing, researching, and trying to understand this illness.


White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
3 clinical-grade skincare creams you really shouldn’t buy online
Eli Lilly Eyes AtaiBeckley Acquisition to Expand Psychedelic Mental Health Pipeline
China vs. NASA: The New Moon Race and What's at Stake by 2030
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Neuralink Expands Brain Implant Trials with 12 Global Patients
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds 



